Frontiers in Pharmacology | Inflammation Pharmacology

Systematic Review

Accepted on 26 May 2025

Effects of dupilumab on quality of life in patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials

in Inflammation Pharmacology

Yunqing Sun
Haibo Liu
Yingjun Gao
Hong Sang
Qingtao Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1587977

190 views

Review

Published on 23 May 2025

Macrophage polarization in disease therapy: insights from astragaloside IV and cycloastragenol

in Inflammation Pharmacology

Bei-Bei Xiong
Yu-Mei Zhuo
Huan Wang
Qiao-Ling Zheng
Feng Tang
Qun Huang
Man Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598022

224 views

Original Research

Accepted on 19 May 2025

-1 -AduCPI2 alleviates MSU-induced acute gouty arthritis in mice by inhibiting cathepsin S and the C5a-C5aR1 axis

in Inflammation Pharmacology

Sijing Liu
Yongli SITU
Zheng Shao
Li DENG
Meng Liang
Bin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604329

106 views

Original Research

Accepted on 19 May 2025

Biodegradable Sustained-Release Microneedle Patch Loaded with Clindamycin Hydrochloride：A Breakthrough in Acne Management

in Inflammation Pharmacology

Haomei Fan
Ruohan Liao
Yiling Yang
Yan Xing
Chengdong Zhang
Xuwei Luo
Chao Pu
Liling WU
Xingping Li
Juhua Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1575635

142 views

Review

Published on 19 May 2025

The key players of inflammasomes and pyroptosis in sepsis-induced pathogenesis and organ dysfunction

in Inflammation Pharmacology

Lujian Zhu
Minli Hu
Haoming Xu
Hanglu Xu
Binbin Ren
Ruiyan Xu
Maodong Guo
Haijun Chen
Dehe Zhang
Hao Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586364

370 views

Review

Published on 19 May 2025

Immunopharmacology of gastric cancer–deciphering immune cell subset responses and nanoparticle-mediated targeting

in Inflammation Pharmacology

Yanting Wang
Ning Ding
Lina Qi
Wenwen Chen
Panyisha Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611234

302 views

Editorial

Published on 16 May 2025

Editorial: Inflammation and lipid signaling in disease pathogenesis

in Inflammation Pharmacology

Paola Patrignani
Bernhard Brüne
Angelo Sala
Pietro Minuz
Dieter Steinhilber

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1623707

310 views

Original Research

Published on 14 May 2025

Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata

in Inflammation Pharmacology

Luning Li
Zhen Sun
Wenxue Sun
Yujuan Zhai
Na Ding
Wei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507348

787 views

Original Research

Published on 14 May 2025

The green tea component (−)-epigallocatechin-3-gallate protects against cytokine-induced epithelial barrier damage in intestinal epithelial cells

in Inflammation Pharmacology

Rita Rosenthal
Anne Waesch
Kopano Valerie Masete
Alain S. Massarani
Jörg-Dieter Schulzke
Nina A. Hering

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559812

343 views

Correction

Published on 13 May 2025

Corrigendum: C16 peptide promotes vascular growth and reduces inflammation in a neuromyelitis optica model

in Inflammation Pharmacology

Haohao Chen
Xiaoxiao Fu
Jinzhan Jiang
Shu Han

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611115

218 views

Original Research

Published on 12 May 2025

Esmolol improves sepsis outcomes through cardiovascular and immune modulation

in Inflammation Pharmacology

Da Jing
Li Xiong
Rong Zhang
Hong Fang
Lin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1498227

357 views

Original Research

Accepted on 09 May 2025

URINARY URODILATIN LEVELS IN PATIENTS WITH RENAL SALT WASTING SYNDROME AS A POSSIBLE NEW DIAGNOSTIC MARKER. A PILOT STUDY

in Inflammation Pharmacology

Vittoriano Della Corte
Luisa Agnello
Rosario Luca Norrito
Marco Cataldi
Matteo Vidali
Rosaria Pecoraro
Carlo Maida
Bruna Lo Sasso
Rosaria Vincenza Giglio
Marcello Ciaccio

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579699

123 views

Review

Accepted on 09 May 2025

Blockade of IL-1 Family Cytokines in the Treatment of Rheumatoid Arthritis

in Inflammation Pharmacology

Kexin Wang
Haoge Luo
Liping Liu
Hang Gao
Dong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1577628

Original Research

Published on 09 May 2025

Suppressing chondrocyte cuproptosis by syringaresinol-4-O-β-d-glucoside alleviates gouty arthritis

in Inflammation Pharmacology

Shaotian Fu
Han Du
Xiao Ling
Hanyi Wang
Jianan Chen
Hang Zhang
Wugui Chen
Chengzhao Liu
Hailong Ma
Chengshou Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565422

579 views

Review

Published on 09 May 2025

Natural saponins and macrophage polarization: Mechanistic insights and therapeutic perspectives in disease management

in Inflammation Pharmacology

Beibei Xiong
Huan Wang
Yi-Xuan Song
Wen-Ying Lan
Jiangtao Li
Fang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1584035

531 views

Original Research

Published on 08 May 2025

Rutin ameliorates LPS-induced acute lung injury in mice by inhibiting the cGAS-STING-NLRP3 signaling pathway

in Inflammation Pharmacology

Xin Zhou
Zhibin Wang
Yuting Wang
Guofeng Xu
Min Luo
Mengwei Zhang
Yuying Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590096

912 views